Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The risk of fracture in incident multiple sclerosis patients: The Danish National Health Registers.
[Research progress of the selective sphingosine-1-phosphate receptor 1 agonists].
FTY720 Impairs Mucosal Immunity and Clearance of the Enteric Pathogen Citrobacter rodentium.
1st International Symposium on Gait and Balance in MS: Gait and Balance Measures in the Evaluation of People with MS.
Comparison of DNA-Hydrolyzing Antibodies from the Cerebrospinal Fluid and Serum of Patients with Multiple Sclerosis.
Interferon Beta Use and Disability Prevention in Relapsing-Remitting Multiple Sclerosis.
Effect of monthly intravenous cyclophosphamide in rapidly deteriorating multiple sclerosis patients resistant to conventional therapy.
A possible case of natalizumab-dependent suicide attempt: A brief review about drugs and suicide.
[Immunodepressive therapy in neurology].
Severe anemia in a patient with multiple sclerosis treated with natalizumab.
Patients' experiences of adapting to multiple sclerosis: a qualitative study.
Role of the innate and adaptive immune responses in the course of multiple sclerosis.
Riluzole increases glutamate uptake by cultured C6 astroglial cells.
Is the treatment of multiple sclerosis headed in the wrong direction?
Alteration of CD1 expression in multiple sclerosis.
TNFRSF1A polymorphisms rs1800693 and rs4149584 in patients with multiple sclerosis.
Expansion of oligodendrocyte progenitor cells following SIRT1 inactivation in the adult brain.
Recommendations on diagnosis and treatment of depression in patients with multiple sclerosis.
Vitamin D-binding protein and vitamin D status of black Americans and white Americans.
The Role of CD8+ T Cells and Their Local Interaction with CD4+ T Cells in Myelin Oligodendrocyte Glycoprotein35-55-Induced Experimental Autoimmune Encephalomyelitis.
Decreased urinary level of melatonin as a marker of disease severity in patients with multiple sclerosis.
A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis.
Progressive outer retinal necrosis in a multiple sclerosis patient on natalizumab.
Stress as a risk factor for multiple sclerosis onset or relapse: a systematic review.
Smoking and Risk of Multiple Sclerosis: Evidence of Modification by NAT1 Variants.

Pages